With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|GeneEditing in T cell Leukemia to Promote Immunomodulatory Forms of Cell Death||Boston Children's Hospital / Dr. Ben Croker, PhD||Innovation Grants||2016||Massachusetts|
|Targeted Inhibition of Lin28/let-7 Binding to Treat Pediatric Malignancy||Boston Children's Hospital / George Q. Daley, MD/PhD||Innovation Grants||2016||Massachusetts|
|Modeling RUNX1-Associated Clonal Hematopoietic Disorders in Zebrafish||Boston Children's Hospital / Leonard Zon, MD||Familial RUNX1 Research Grants||2016||Massachusetts|
|Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML||Boston Children's Hospital / Alan Cantor, MD, PhD||Familial RUNX1 Research Grants||2016||Massachusetts|
|Role of N6-Methyladenosine (m6A) mRNA Modification Pathway in Neuroblastoma||Boston Children's Hospital / Shuibin Lin, PhD||Young Investigator Grants||2017||Massachusetts|
|Understanding the Mechanisms of HOX Gene Regulation in Normal and Leukemic Hematopoietic Stem Cells to Identify New Therapies for Pediatric AML||Boston Children's Hospital / Anne Robertson, PhD||Young Investigator Grants||2017||Massachusetts|
|Mechanisms of Oncogenic Transformation by TLX1/HOX11||University of Michigan / Mark Chiang||Young Investigator Grants||2011||Michigan|
|Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma||University of Michigan / Carl Koschmann, MD||Young Investigator Grants||2014||Michigan|
|Mechanisms of LGR5 Regulation and Function in Ewing sarcoma Metastasis||University of Michigan / Elizabeth Lawlor, M.D., Ph.D.||Innovation Grants||2014||Michigan|
|Engager T Cells: A Novel Immunotherapeutic for AML||University of Michigan / Challice Bonifant, MD, PhD||Young Investigator Grants||2015||Michigan|